z-logo
open-access-imgOpen Access
Bortezomib sensitizes non-small cell lung cancer to mesenchymal stromal cell-delivered inducible caspase-9-mediated cytotoxicity
Author(s) -
M. Ando,
V. Hoyos,
S. Yagyu,
W. Tao,
C.A. Ramos,
G. Dotti,
M.K. Brenner,
L. Bouchier-Hayes
Publication year - 2014
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - Uncategorized
DOI - 10.17615/n75q-ep82
Subject(s) - bortezomib , mesenchymal stem cell , cytotoxicity , cancer research , stromal cell , cell , lung cancer , medicine , chemistry , oncology , multiple myeloma , pathology , in vitro , biochemistry

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom